Literature DB >> 9334721

Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy.

E S Withers-Ward1, R G Amado, P S Koka, B D Jamieson, A H Kaplan, I S Chen, J A Zack.   

Abstract

Stem cell gene therapy strategies for AIDS require that differentiation-inducing stromal elements of HIV-infected individuals remain functionally intact to support the maturation of exogenous progenitor cells into mature CD4+ cells. To investigate the feasibility of stem cell reconstitution strategies in AIDS, we used the SCID-hu mouse to examine the ability of HIV-infected CD4+ cell-depleted human thymic implants to support renewed thymopoiesis. Here we report that following treatment of these implants with antiretroviral drugs, new thymopoiesis is initiated. This suggests that antiviral therapies might allow de novo production of T lymphocytes and provides support for the concept of therapeutic strategies aimed at reconstitution of the peripheral CD4+ T-cell compartment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334721     DOI: 10.1038/nm1097-1102

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  26 in total

1.  Functional reconstitution of thymopoiesis after human immunodeficiency virus infection.

Authors:  S G Kitchen; S Killian; J V Giorgi; J A Zack
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  HIV latency in the humanized BLT mouse.

Authors:  Matthew D Marsden; Michael Kovochich; Nuttee Suree; Saki Shimizu; Roshni Mehta; Ruth Cortado; Gregory Bristol; Dong Sung An; Jerome A Zack
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 3.  A challenge for the future: aging and HIV infection.

Authors:  Tammy M Rickabaugh; Beth D Jamieson
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

4.  Latent reservoirs of HIV: obstacles to the eradication of virus.

Authors:  T W Chun; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  Human immunodeficiency virus inhibits multilineage hematopoiesis in vivo.

Authors:  P S Koka; J K Fraser; Y Bryson; G C Bristol; G M Aldrovandi; E S Daar; J A Zack
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  Contact with thymic epithelial cells as a prerequisite for cytokine-enhanced human immunodeficiency virus type 1 replication in thymocytes.

Authors:  M Rothe; L Chêne; M T Nugeyre; J Braun; F Barré-Sinoussi; N Israël
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  High-level replication of human immunodeficiency virus in thymocytes requires NF-kappaB activation through interaction with thymic epithelial cells.

Authors:  L Chêne; M T Nugeyre; F Barré-Sinoussi; N Israël
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice.

Authors:  Scott G Kitchen; Michael Bennett; Zoran Galić; Joanne Kim; Qing Xu; Alan Young; Alexis Lieberman; Aviva Joseph; Harris Goldstein; Hwee Ng; Otto Yang; Jerome A Zack
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

9.  Targeting c-Mpl for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34+ progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo.

Authors:  Prasad S Koka; Christina M R Kitchen; Srinivasa T Reddy
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 10.  The utilization of humanized mouse models for the study of human retroviral infections.

Authors:  Rachel Van Duyne; Caitlin Pedati; Irene Guendel; Lawrence Carpio; Kylene Kehn-Hall; Mohammed Saifuddin; Fatah Kashanchi
Journal:  Retrovirology       Date:  2009-08-12       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.